BIONTECH CEO SAHIN SAYS FIRST 5-8 COMPANIES WITH APPROVED VACCINES WILL NOT STAND IN EACH OTHERS WAY, ONLY AFTER MID 2021 WILL THEY COMPETE WITH THEIR SPECIFIC PRODUCT PROFILES
A perfect mix of quantitative & qualitative Bile Duct Cancer Drug market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Bile Duct Cancer Drug market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.
The Bile Duct Cancer Drug Market report also provides the market impact and new opportunities created due to the COVID19/CORONA Virus Catastrophe The total market is further divided by company, by country, and by application/types for the competitive landscape analysis. The report then estimates 2020-2025 market development trends of Bile Duct Cancer Drug Industry.
Request For Exclusive Free Sample PDF along with few company profiles
The Top players are Ariad Pharmaceuticals, Inc., ArQule, Inc., Array BioPharma Inc., Arrien Pharmaceuticals, LLC, Aslan Pharmaceuticals Pte. Ltd., Bavarian Nordic A/S, Bayer AG, Blueprint Medicines Corporation, Boehringer Ingelheim GmbH, Boston Biomedical, Inc., Bristol-Myers Squibb Company, Celgene Corporation, CellAct Pharma GmbH, Cellceutix Corporation, Cellular Biomedicine Group, Inc., Concordia Healthcare Corp..
By Product Type: Cabozantinib S-malate, Elpamotide, Exatecan Mesylate, LY-2801653, NUC-1031, Others
On the basis of the end users/applications, Hospital, Clinic, Others
Downlaod Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies.
Be the first to knock the door showing the potential that Bile Duct Cancer Drug market is holding in it. Uncover the Gaps and Opportunities to derive the most relevant insights from our research document to gain market size.
A major chunk of this Global Bile Duct Cancer Drug Market research report is talking about some significant approaches for enhancing the performance of the companies. Marketing strategies and different channels have been listed here. Collectively, it gives more focus on changing rules, regulations, and policies of governments. It will help to both established and new startups of the market.
The study objectives of this report are:
To analyze global Bile Duct Cancer Drug status, future forecast, growth opportunity, key market, and key players.
To present the Bile Duct Cancer Drug development in the United States, Europe, and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market, and key regions.
Get Special Discount Up To 50%,
Industrial Analysis of Bile Duct Cancer Drug Market:
Major Points from Table of Contents
1 Bile Duct Cancer Drug Bile Duct Cancer Drug Market Overview
2 Bile Duct Cancer Drug Market Competition by Manufacturers
3 Production Capacity by Region
4 Global Bile Duct Cancer Drug Market by Regions
5 Production, Revenue, Price Trend by Type
6 Global Bile Duct Cancer Drug Market Analysis by Application
7 Company Profiles and Key Figures in Bile Duct Cancer Drug Business
8 Bile Duct Cancer Drug Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Production and Supply Forecast
12 Consumption and Demand Forecast
13 Forecast by Type and by Application (2021-2026)
14 Research Finding and Conclusion
15 Methodology and Data Source.
ENQUIRE MORE ABOUT THIS REPORT AT
FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Contact Name: Rohan S.
UK: +44 (203) 743 1898
Record-keeping requirements will also be an overwhelming task, officials said. The C.D.C. wants to track, in real time, the age, sex, race and ethnicity of everyone who is vaccinated — states usually provide such data quarterly, at best — so it can analyze how well the vaccination campaign is going among different demographic groups day by day and make adjustments if certain populations or regions have low vaccination rates. The C.D.C., which holds frequent planning calls with state and local health officials, is also still working on persuading states to hand over the personal data of their citizens. The agency has requested each vaccine recipient’s name, date of birth, address, race, ethnicity and certain medical history.
As soon as the F.D.A. approves a vaccine, the C.D.C.’s Advisory Committee on Immunization Practices will meet to issue recommendations, already in the works, on how it should be distributed. It will almost certainly say that health care workers should be the group with the highest priority for vaccination, followed by essential service workers, people with high-risk medical conditions and those older than 65.
But states will be allowed flexibility within those guidelines; Maryland, for example, plans to include its prison and jail populations in its “Phase 1” priority group. State officials also have to figure out whom to focus on within priority populations if they get less vaccine than they need.
During the C.D.C. advisory committee’s meeting last month, some members said they wanted to ensure that information about any safety problems would be made public quickly.Until now, the F.D.A. and the C.D.C. have maintained one data system for patients or providers to report bad reactions to vaccines. They plan to supplement that system with a smartphone-based tool that checks in with individuals who have been vaccinated to see whether they have had any health problems.
The C.D.C. advisory group has also stressed the importance of a campaign to persuade the public to take the vaccine, noting that messages were likely to be more effective if they came from community leaders than from the federal government. North Carolina says its campaign will use “photos, video, and personal testimony of celebrities, leaders of historically marginalized populations, and other trusted messengers receiving vaccine as early adopters.”
To ease the burden on health departments, the federal government is contracting with CVS and Walgreens pharmacies to vaccinate residents of nursing homes and other long-term-care centers around the country. But it could be difficult to reach those in isolated regions, and some might opt out of the program. Last week, the administration announced the federal government would contract with pharmacies to provide the vaccine generally, as they do with flu shots, once supplies of it increase next year.
The timing could hardly have been better. In the week that the daily number of US Covid-19 cases relentlessly hit new records and just days after England followed much of the rest of Europe into lockdown, Pfizer and BioNTech announced their vaccine was 90% effective against the virus.
The news came too late to prevent a new hit to growth in the final three months of 2020. Nor will it be enough to prevent the central banks in the US and the eurozone from piling in with fresh stimulus packages in the weeks to come.
But hopes of a treatment for the virus that has caused such damage to the global economy this year does boost confidence that better times are ahead in 2021.
Moreover, it – and further announcements to come – increase the chance that there will be upward revisions to growth forecasts in the months ahead. Anthony Fauci, America’s top infectious disease expert, says he expects more good news to come from Moderna’s stage 3 trial within the next few days.
Financial markets were certainly in no doubt that there was finally light at the end of the long Covid-19 tunnel. Shares in companies most affected by social distancing – airlines, cinemas, brewers, hotels – all soared in a powerful vaccine rally.
Hande Küçük, deputy director of macroeconomic modelling and forecasting at the National Institute for Economic and Social Research (NIESR), said: “The economic impact of of Covid-19 not only comes from lockdowns and restrictions but from voluntary social distancing. If vaccines reduce the fear of being infected it might have a big impact on the recovery.”
Küçük added that NIESR’s forecast of 5.9% UK growth in 2021 had assumed that vaccines would become available from the middle of next year, but she said there was now a possibility of “a quicker recovery in the first and second quarters.”
Ben May, global economy analyst at Oxford Economics, said the vaccine was a “major step forward” which should help limit the long-term scarring to the economy by persuading policymakers to continue with plans that would prevent lay offs and bankruptcies.
While not yet ready to revise his forecasts, May said he didn’t rule out the possibility of doing so eventually. “There would need to be evidence that vaccines were going to be in circulation very quickly and give governments the ability to reduce restrictions very quickly.”
He added that the stock market reaction was understandable. “News on vaccines provides hope to people in these sectors that if they are patient they will have a viable business model again.”
New data released last week showed that, after declining in the first and second quarters of 2020, the UK economy grew by a record 15.5% between July and September. But the pace of activity slowed even before the latest restrictions to combat the virus were imposed. Most forecasts expect the economy to contract again in the fourth quarter and to shrink by around 11% in 2020 overall.
Thomas Pugh, UK economist at Capital Economics, said the outlook for next year was now more encouraging: “We have pencilled in a [growth] hit of 8% in November. That would result in a 3.5% contraction in the fourth quarter. But the recent news of a potentially effective vaccine means that the outlook beyond the next six months could be much rosier than we have previously anticipated.”
Policymakers tended to be more cautious, in part because their own growth forecasts have already assumed that the efforts to find a vaccine would be successful before too long.
In its half-yearly World Economic Outlook in October, the International Monetary Fund said it expected global growth of 5.2% next year on the assumption that social distancing would continue into 2021 but would then fade over time as vaccine coverage expanded.
However, the IMF added that a speedier recovery was possible. “Progress with vaccines and treatments, as well as changes in the workplace and by consumers to reduce transmission, may allow activity to return more rapidly to pre-pandemic levels than currently projected, without triggering repeated waves of infection.”
Speaking after the Pfizer-BioNTech announcement, Jerome Powell, the chairman of the Federal Reserve, said it was “just too soon” to assess the impact of the vaccine but that more US economic support was still needed. Christine Lagarde, the president of the European Central Bank, also downplayed the possibility of an immediate upward revision to eurozone forecasts.
Andrew Bailey, the governor of the Bank of England, told a Financial Times event that the vaccine news was encouraging and chimed with Threadneedle Street’s view that there would be a gradual improvement in the economy as treatments for the virus improved.
But he also urged caution: “I think we have to be cautious because there’s still quite a way to go in trialling [a vaccine], in production and distribution, and putting all this into action.”
From social media posts to bilingual help lines, Sacramento County health officials are making efforts this season to make sure the hardest-to-reach people know how to get a flu shot.
Experts say widespread adherence to the flu vaccine could help prevent parallel spikes in influenza and COVID-19, and lessen the burden on health care systems. The two illnesses share some symptoms, and an influx of patients this winter could pose a challenge to emergency room staff.
“We really need to conserve resources this year,” said Rachel Allen, senior health program coordinator for Sacramento County’s immunization assistance program.
The county is teaming up with trusted organizations in underserved neighborhoods to reach low-income residents, homeless individuals and others who may skip the flu shot because they think they can’t afford it, don’t know where to get it, or don’t have transportation to a vaccination site.
Additional sites have been set up, including drive-through locations for people who may be nervous about getting vaccinated during the pandemic. Allen says the county had the free flu clinic listing posted in six languages, which is more than any translation effort they’ve undertaken in the past.
“This year has been a dry run for COVID,” Allen said. “We are using every one of our clinics whether they’re walk-up or drive-through … to make it accommodate what we’re going to need for a COVID vaccine.”
Allen says they don’t have exact information on when a COVID-19 vaccine might be available and who it would be distributed to first.
To advertise the flu shot, Sacramento County is working with multicultural sites such as La Familia Counseling Center and Sacramento’s Mexican Consulate to get the word out about free vaccines.
Liliana Ferrer, Consul General of Mexico in Sacramento, said this is an important time for Mexican-Americans, especially those who are essential workers, to be protected from the flu.
“They’re fearful to come out, especially if they don’t have insurance or they don’t know where to get one,” she said. “The Mexican Consulate is a place of trust, it’s a place of safety for our community … free of charge, no questions asked, with full respect to privacy and confidentiality.”
She says staff at the consulate are trying to talk about the flu vaccine with people who come in for a COVID-19 test. They’ve provided over 3,000 COVID-19 tests so far, and administered over 500 flu vaccines since they started offering the shot in November.
Getting the word to families about flu shots is even trickier this year without on-site flu options and teachers talking to parents, said pediatrician Dr. Beatrice Tetteh. She runs a clinic near the Pocket where about 60% of patients are on Medi-Cal, the state’s low-income health program.
She says she spends a lot of time educating parents who have doubts about the flu vaccine.
“I have people that come in and they are following advice from their aunties or their grandma or grandpa,” she said. “And not that they’re all wrong, it’s just when it comes to medical things, most of our health care practitioners are the ones who are sharing with you these recommendations because we’re trying to keep you healthy.”
For some people, it takes getting the flu or knowing someone who got sick to convince them to get a shot the following season, Tetteh said. She expects that trend will continue if a COVID-19 vaccine becomes available.
“There are people that believe that vaccines are unnecessary, that our immune systems are strong enough on their own,” she said. “And one conversation I often have with parents about this is letting them know that vaccines are the way that our immune systems get trained to be strong … I think that there’s going to still be people that will not want to do a COVID-19 vaccine.”
It’s not too late to get a flu shot, as the season could continue through early 2021. Experts are predicting that this flu season will be mild, based on trends in the Southern hemisphere.
Find the county’s list of free flu clinics here. They also have an immunization help line: 916-875-7468